By clarifying leptin’s regulation of lipids and glucose metabolism in breast cancer cell migration, this work may inform development of therapies to reduce obesity-associated metastatic breast cancer. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.